QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

Aldoxorubicin hydrochloride

Recombinant human super agonist interleukin-15 (IL-15) complex

Ad5 \[E1-, E2b-\]-CEA

Ad5 \[E1-, E2b-\]-Brachyury vaccine

Ad5 \[E1-, E2b-\]-MUC1

Vaccine derived from recombinant Saccharomyces cerevisiae yeast expressing mutant Ras proteins

Vaccine derived from recombinant Saccharomyces cerevisiae yeast expressing mutant CEA proteins

Vaccine derived from recombinant Saccharomyces cerevisiae yeast expressing mutant Brachyury yeast proteins

NK-92 \[CD16.158V, ER IL-2\]

Recombinant human anti-PD-L1 IgG1 monoclonal antibody

Recombinant human anti-VEGF IgG1 monoclonal

5'-deoxy-5-fluoro-N-\[(pentyloxy) carbonyl\]-cytidine

cis-diamminedichloroplatinum(II)

2-\[bis(2-chloroethyl)amino\]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate

5-fluoro-2,4 (1H,3H)-pyrimidinedione

L-Glutamic acid, N-\[4-\[\[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl\]amino\]benzoyl\]-, calcium salt

Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-(2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4,11-dihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca\[3,4\]benz\[1,2-b\]oxet-9-y1ester,(αR,βS)-(9CI) bound to albumin

Stereotactic Body Radiation Therapy